Watson Noel Bertram sold $156K of AFRM

Watson Noel Bertram sold 2,000 shares of Affirm Holdings, Inc. (AFRM) at $77.86 ($0.16M total) on 2026-08-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Watson Noel Bertram
Published Aug 14, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AFRM
Neutral
high confidence
Mentioned
$AFRM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFRMNeutralLow
01

Why it matters

A director’s planned open-market sale is typically treated as low-signal for fundamentals, but it can marginally influence short-term sentiment among retail and momentum traders.

02

Market read

Traders may note the sale for sentiment, but there is no new guidance, deal, or regulatory development in the text.

03

What to watch

The disclosure does not indicate whether the sale was part of a broader planned selling schedule beyond the stated 10b5-1 plan, nor does it provide context on total insider holdings changes over time.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-14, transaction dated 2026-08-12

Background

The article is an SEC Form 4 insider transaction disclosure for Affirm Holdings, Inc.

Company-level read

Ticker impact

$AFRMNeutralHigh confidence
Context

Affirm director Watson Noel Bertram sold 2,000 shares on 2026-08-12 at $77.86 under a pre-arranged 10b5-1 plan, per Form 4.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and short-lived.

Evidence & confidence

The filing is an open-market sale by a director executed under a pre-arranged 10b5-1 plan, with no accompanying operational, financial, or regulatory change disclosed.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Insider selling can still be interpreted as risk management or valuation concerns, even when executed under 10b5-1, especially if multiple insiders sell around the same period.

Key entities

  • Affirm Holdings, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Watson Noel Bertram

    Director who sold 2,000 shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFRMMed

Levchin Says Affirm Is Moving With “Deliberate Aggression.” Ratepay Takes It Into Germany in 2027

Affirm (AFRM) agreed to acquire Ratepay, a German pay-by-invoice provider, from Nexi (NEXI), with the deal expected to close in the first half of 2027. Affirm's revenue rose 35% to $1.26 billion, but credit losses increased 59%. The company's international expansion is minimal, with Europe contributing little to growth. Affirm has $3.0 billion in liquidity and plans to add installment loans in Germany.

$AFRMMed

Mizuho reiterates Affirm stock rating on path to 2030 earnings goal

Mizuho reiterated an Outperform rating and $100 price target for Affirm (AFRM), citing Q1 fiscal 2027 results supporting its 2030 earnings goal. AFRM stock is down 2.61% in the past week, trading at $67.84. Gross merchandise volume grew 34% to $14.4 billion, and revenue rose 32.69% to $4.59 billion. Analysts have mixed reactions to AFRM's performance and future prospects.

$AFRMMed

Chime and Affirm Show the Trade-Offs Behind Credit Growth

Chime and Affirm are expanding credit offerings. Chime's Prime members can access credit lines with $3,000 monthly deposits, while Affirm's debit card extends installment loans to non-partner retailers. Chime reported higher losses due to increased borrowing, with first-time borrowers driving losses. Affirm's card transactions are mostly interest-bearing, with plans to introduce card-specific financing offers.

$AFRMMedAI 8/10

Affirm and Nuvei Seek Bigger Roles in Payment Operations

Affirm agreed to acquire Ratepay, a German payments company, expanding its merchant network in Germany, Austria, and Switzerland. The deal is expected to close in 2027. Nuvei announced a $2.75B acquisition of Payoneer, adding cross-border payout and multi-currency services. Payoneer's Q3 earnings showed growth in enterprise payouts and B2B volume. Both deals aim to enhance embedded finance capabilities for merchants.

$UPSTHigh

Upstart Sinks 11% as Hot Inflation Report Hits Fintech Lenders; SoFi Falls 4%, Affirm Slides 3%

Upstart Holdings (UPST) fell 11% to $19.87 after a hot inflation report increased expectations of a Fed rate hike, impacting its rate-sensitive business. The company revised its 2026 revenue and EBITDA guidance downward, citing macroeconomic headwinds. SoFi (SOFI) and Affirm (AFRM) also declined but less sharply, as their funding models are less sensitive to rate changes. Analysts lowered UPST's EPS estimates, with a consensus price target of $31.19.